NEUROTOXICOLOGICAL TESTING OF CLINICAL CANDIDATE DRUGS NIH GUIDE, Volume 26, Number 13, April 25, 1997 RFP AVAILABLE: N01DA-7-8078 P.T. 34 Keywords: Toxicology Chemotherapeutic Agents National Institute on Drug Abuse The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having in-house capability to conduct studies of neurotoxicology in rodents. Clinical candidate test compounds will be evaluated and the resulting data will be utilized by the NIDA Medications Development Division. Offerors must indicate possession of current DEA registration for Schedule II-V substances prior to award and apply for Schedule I registration at the time of award. It is anticipated that one (1) cost reimbursement, completion type contract will be awarded for a period of three years, with possibilities for two one-year options and other option quantities for additional follow-up studies and/or compound evaluations. RFP No. N01DA-7-8078 will be available electronically on or about May 1, 1997, and may be accessed through the NIH Gopher and/or the Internet by using the following electronic mail addresses and instruction: 1. NIH Home Page (via the World Wide Web): Access the NIH Home Page by using http://www.nih.gov . Once you are at the NIH Home Page, select "Grants and Contracts"; select "NIH Gopher directory: listed under the "Contracts Page" section. Once at the NIH R&D Gopher, select "RFPs Available"; select "NIDA"; and select "RFP N01DA-7- 8078". (URL: gopher://gopher.nih.gov:70/11/res/rd-rfp) 2. NIH Gopher: Point your Gopher client to GOPHER.NIH.GOV Port 70 (you should now be in the NIH Gopher). Select "Grant and Research Information"; select "R&D Request for Proposals (RFP)"; select "RFPs Available"; select "NIDA"; and, select "RFP N01DA-7-8078". Please note that the RFP for this acquisition will be streamlined to include only the Work Statement, deliverable and reporting requirements, special requirements and mandatory qualifications, Technical Evaluation Criteria, and proposal preparation instructions. All information required for the submission of an offer will be contained in the electronic RFP package. INQUIRIES Response to this RFP will be due on or about June 16, 1997. Any responsible offeror may submit a proposal that will be considered by the Government. This advertisement does not commit the Government to award a contract. Kenneth E. Goodling Contracts Management Branch National Institute on Drug Abuse 5600 Fishers Lane, Room 10-49 Rockville, MD 20857 Telephone: (301) 443-6677 FAX: (301) 443-7595 Email: kg25d@nih.gov .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |